Metabolic Pathway Research ·

SurvodutideBI 456906 - GLP-1/glucagon dual agonist

Dual GLP-1/glucagon receptor agonist research

Also known as BI 456906 - GLP-1/glucagon dual agonist. CAS No. 2375817-96-2.

3 papers·Phase III·COA Verified·0 saved

Lowest /mg now

$10.00

Orbitrex Peptides

$10.00–$21.90 range

Scientific name

BI 456906 - GLP-1/glucagon dual agonist

CAS No.

2375817-96-2

Category

Metabolic Pathway Research

US status

Research only

Evidence last verified May 9, 2026

2 results

Product	Vendor	Size	Price	$/mg	Purity	COA
Survodutide 10mg	AOrbitrex Peptides	10mg	$99.99	$10/mg	99%	Finnrick9d	Visit
Survodutide	ASkye Peptides	6mg	$99	$16.50/mg	99.7%	Finnrick12d	Visit
Survodutide	ASkye Peptides	10mg	$219	$21.90/mg	99.7%	Finnrick12d	Visit
Survodutide	ASkye Peptides	12mg	$149	$12.42/mg	99.7%	Finnrick12d	Visit
Survodutide	ASkye Peptides	30mg	$589	$19.63/mg	99.7%	Finnrick12d	Visit

Scientific Details

Scientific Research

Year	Title / Journal	Type	Cites
2024	Sanyal 2024 — Survodutide in MASH and Fibrosis New England Journal of Medicine	RCT	484
2024	le Roux 2024 — Survodutide Phase 2 Obesity Trial The Lancet Diabetes & Endocrinology	RCT	205
2024	le Roux 2024 - Survodutide Phase 2 Trial for Obesity The Lancet Diabetes & Endocrinology	RCT	205

Showing 3 of 3 papers

Regulatory Status

USResearch only

EUNot approved

UKResearch only

AUResearch only

Regulatory status may change. Always verify current regulations in your jurisdiction before purchase.